# OnCo record paul-nathan (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/paul-nathan/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "paul-nathan" ;
  schema:name "Paul Nathan"@en ;
  schema:description "Led the tebentafusp trial, the first treatment ever to extend survival in metastatic uveal melanoma."@en ;
  schema:url <https://onco.cc/people/paul-nathan/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Nathan%20P%5BAuthor%5D%20tebentafusp> ;
  onco:tag "uveal-melanoma", "bispecific", "uk" ;
  schema:jobTitle "Consultant Medical Oncologist, Mount Vernon Cancer Centre, London" ;
  onco:cancers <https://onco.cc/cancers/uveal-melanoma/>, <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/> ;
  onco:targets <https://onco.cc/targets/gp100/>, <https://onco.cc/targets/cd3/> ;
  onco:drugs <https://onco.cc/drugs/tebentafusp/> ;
  onco:institutions <https://onco.cc/institutions/mount-vernon-cancer-centre/> ;
  onco:trials <https://onco.cc/trials/imcgp100-202/> ;
  schema:affiliation <https://onco.cc/institutions/mount-vernon-cancer-centre/> .